Compound ID |
Compound Name |
Compound Formula |
CP0428003
|
2-(4-anilino-5-oxo-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-6-yl)-N-benzyl-N-propan-2-ylacetamide
Show/Hide
|
C34H32N6O2
|
2
|
1 |
EC50 = 91.3 nM
|
|
|
2 |
IC50 = 24.3 nM
|
|
|
CP0488798
|
3-((6-(2-(isopropyl(phenyl)amino)-2-oxoethyl)-5-oxo-1-phenyl-5,6-dihydro-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-4-ylamino)benzoic acid
Show/Hide
|
C34H30N6O4
|
2
|
1 |
EC50 = 160 nM
|
|
|
2 |
IC50 = 19.7 nM
|
|
|
CP0379239
|
(S)-3-(3-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)ureido)benzoic acid
Show/Hide
|
C34H31N5O6
|
2
|
1 |
EC50 = 283 nM
|
|
|
2 |
IC50 = 131 nM
|
|
|
CP0373240
|
2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-6(5H)-yl)-N-benzyl-N-isopropylacetamide
Show/Hide
|
C37H34N6O2
|
3
|
1 |
EC50 = 315 nM
|
|
|
2 |
IC50 = 23.6 nM
|
|
|
3 |
IC50 = 31.7 nM
|
|
|
CP0373242
|
2-(4-(1H-indazol-3-yl)-5-oxo-1-phenyl-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-6(5H)-yl)-N-benzyl-N-isopropylacetamide
Show/Hide
|
C35H31N7O2
|
2
|
1 |
EC50 = 522 nM
|
|
|
2 |
IC50 = 48.5 nM
|
|
|
CP0379560
|
N-benzyl-2-(5-oxo-4-phenoxy-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-6-yl)-N-propan-2-ylacetamide
Show/Hide
|
C34H31N5O3
|
2
|
1 |
EC50 = 628 nM
|
|
|
2 |
IC50 = 15 nM
|
|
|
CP0386006
|
3-(6-(2-(benzyl(isopropyl)amino)-2-oxoethyl)-5-oxo-1-phenyl-5,6-dihydro-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-4-ylamino)benzoic acid
Show/Hide
|
C35H32N6O4
|
2
|
1 |
EC50 = 645 nM
|
|
|
2 |
IC50 = 49.3 nM
|
|
|
CP0386005
|
2-(4-benzyl-5-oxo-1-phenyl-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-6(5H)-yl)-N-isopropyl-N-phenylacetamide
Show/Hide
|
C34H31N5O2
|
2
|
1 |
EC50 = 1810 nM
|
|
|
2 |
IC50 = 201 nM
|
|
|
CP0386007
|
2-((4R)-4-(1H-indol-3-yl)-5-oxo-1-phenyl-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-6(5H)-yl)-N-benzyl-N-isopropylacetamide
Show/Hide
|
C36H32N6O2
|
2
|
1 |
EC50 > 10000 nM
|
|
|
2 |
IC50 = 246 nM
|
|
|
CP0035682
|
3-(4-(5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-(2-fluoro-4-methylphenyl)pyrimidine-2-carbonyl)piperazin-1-yl)-1-naphthoic acid
Show/Hide
|
C35H29FN4O5
|
1
|
1 |
IC50 = 0.034 nM
|
|
|
CP0037352
|
(3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-amino-3-formamidopropanoic acid]-3-[4-(sulfooxy)phenyl]propanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid
Show/Hide
|
C49H62N10O16S3
|
2
|
1 |
IC50 = 0.13 nM
|
|
|
2 |
IC50 = 0.3981 nM
|
|
|
CP0522025
|
(5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-p-tolylpyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C33H29N5O3
|
1
|
1 |
IC50 = 0.18 nM
|
|
|
CP0331610
|
3-(4-(4-(2-fluoro-4-methylphenyl)-5-(4-methoxyphenyl)pyrimidine-2-carbonyl)piperazin-1-yl)-1-naphthoic acid
Show/Hide
|
C34H29FN4O4
|
1
|
1 |
IC50 = 0.22 nM
|
|
|
CP0504604
|
(4-(2-fluoro-4-methylphenyl)-5-(4-methoxyphenyl)pyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C32H28FN5O2
|
1
|
1 |
IC50 = 0.26 nM
|
|
|
CP0795225
|
1-(3-Thiophen-2-yl-phenyl)-ethanone, O-(phenylaminocarbonyl)oxime
Show/Hide
|
C19H16N2O2S
|
1
|
1 |
IC50 = 1 nM
|
|
|
CP0502594
|
(4-(2-fluorophenyl)-5-(4-methoxyphenyl)pyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C31H26FN5O2
|
1
|
1 |
IC50 = 1.4 nM
|
|
|
CP0441277
|
3-(4-(5-(4-methoxyphenyl)-4-p-tolylpyrimidine-2-carbonyl)piperazin-1-yl)-1-naphthoic acid
Show/Hide
|
C34H30N4O4
|
1
|
1 |
IC50 = 2 nM
|
|
|
CP0441275
|
(5-(4-ethoxyphenyl)-4-p-tolylpyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C33H31N5O2
|
1
|
1 |
IC50 = 2.4 nM
|
|
|
CP0479098
|
(5-(4-methoxyphenyl)-4-p-tolylpyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C32H29N5O2
|
1
|
1 |
IC50 = 2.4 nM
|
|
|
CP0408734
|
6-[2-[2-(cyclohexylmethyl)piperidin-1-yl]-2-oxoethyl]-4-(1H-indol-3-ylmethyl)-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C39H42N6O2
|
1
|
1 |
IC50 = 4.24 nM
|
|
|
CP0509266
|
methyl 3-[4-[5-(4-methoxyphenyl)-4-(4-methylphenyl)pyrimidine-2-carbonyl]piperazin-1-yl]naphthalene-1-carboxylate
Show/Hide
|
C35H32N4O4
|
1
|
1 |
IC50 = 4.7 nM
|
|
|
CP0453848
|
(3S)-3-[[2-[[(2S)-2-acetamido-3-(1H-indol-3-yl)propanoyl]amino]-6-[(2-chlorophenyl)carbamoylamino]hexanoyl]amino]-4-[[(2R)-1-amino-3-(4-methylphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
Show/Hide
|
C40H47ClN8O8
|
1
|
1 |
IC50 = 5.012 nM
|
|
|
CP0441279
|
(4-(4-fluorophenyl)-5-(4-methoxyphenyl)pyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C31H26FN5O2
|
1
|
1 |
IC50 = 6.7 nM
|
|
|
CP0422848
|
(4-(benzofuran-6-yl)piperazin-1-yl)(5-(4-methoxyphenyl)-4-p-tolylpyrimidin-2-yl)methanone
Show/Hide
|
C31H28N4O3
|
1
|
1 |
IC50 = 9.9 nM
|
|
|
CP0537621
|
(4S)-4-(2H-indazol-3-ylmethyl)-6-[2-[2-(2-methoxyethyl)piperidin-1-yl]-2-oxoethyl]-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C34H35N7O3
|
1
|
1 |
IC50 = 9.9 nM
|
|
|
CP0372233
|
(4-(isoquinolin-3-yl)piperazin-1-yl)(5-(4-methoxyphenyl)-4-p-tolylpyrimidin-2-yl)methanone
Show/Hide
|
C32H29N5O2
|
1
|
1 |
IC50 = 13 nM
|
|
|
CP0372228
|
(5-(4-methoxyphenyl)-4-p-tolylpyrimidin-2-yl)(4-(naphthalen-2-yl)piperazin-1-yl)methanone
Show/Hide
|
C33H30N4O2
|
1
|
1 |
IC50 = 16.9 nM
|
|
|
CP0494368
|
(5-(4-methoxyphenyl)-4-phenylpyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C31H27N5O2
|
1
|
1 |
IC50 = 17.9 nM
|
|
|
CP0441276
|
(5-(4-methoxyphenyl)-4-p-tolylpyrimidin-2-yl)(4-(quinolin-6-yl)piperazin-1-yl)methanone
Show/Hide
|
C32H29N5O2
|
1
|
1 |
IC50 = 19 nM
|
|
|
CP0511970
|
(3S)-3-[[2-[[(2S)-2-acetamido-3-(1H-indol-3-yl)propanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexanoyl]amino]-4-[[(2R)-1-amino-3-(4-methylphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
Show/Hide
|
C41H50N8O8
|
1
|
1 |
IC50 = 19.95 nM
|
|
|
CP0374787
|
(4S)-6-[2-[(2R)-2-[(3,5-dimethylphenyl)methyl]piperidin-1-yl]-2-oxoethyl]-4-(2H-indazol-3-ylmethyl)-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C40H39N7O2
|
1
|
1 |
IC50 = 20.3 nM
|
|
|
CP0467649
|
(5-(3-ethoxyphenyl)-4-p-tolylpyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C33H31N5O2
|
1
|
1 |
IC50 = 25 nM
|
|
|
CP0449811
|
(3S)-3-[[2-[[(2S)-2-acetamido-3-(1H-indol-3-yl)propanoyl]amino]-3-[4-[(2-methylphenyl)carbamoylamino]phenyl]propanoyl]amino]-4-[[(2R)-1-amino-3-(4-methylphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
Show/Hide
|
C44H48N8O8
|
1
|
1 |
IC50 = 31.62 nM
|
|
|
CP0494364
|
(5-(3-methoxyphenyl)-4-p-tolylpyrimidin-2-yl)(4-(naphthalen-2-yl)piperazin-1-yl)methanone
Show/Hide
|
C33H30N4O2
|
1
|
1 |
IC50 = 33 nM
|
|
|
CP0479097
|
(5-(3-methoxyphenyl)-6-p-tolylpyridin-2-yl)(4-(naphthalen-2-yl)piperazin-1-yl)methanone
Show/Hide
|
C34H31N3O2
|
1
|
1 |
IC50 = 35 nM
|
|
|
CP0498671
|
(4-(2-chlorophenyl)-5-(4-methoxyphenyl)pyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C31H26ClN5O2
|
1
|
1 |
IC50 = 35 nM
|
|
|
CP0502593
|
(5-(3-methoxyphenyl)-4-p-tolylpyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C32H29N5O2
|
1
|
1 |
IC50 = 35 nM
|
|
|
CP0444321
|
(4S)-6-[2-(2-benzylpiperidin-1-yl)-2-oxoethyl]-4-(2H-indazol-3-ylmethyl)-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C38H35N7O2
|
1
|
1 |
IC50 = 36 nM
|
|
|
CP0537620
|
6-[2-(2-ethylpiperidin-1-yl)-2-oxoethyl]-4-(1H-indol-3-ylmethyl)-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C34H34N6O2
|
1
|
1 |
IC50 = 36.9 nM
|
|
|
CP0517274
|
N-benzyl-2-[(4S)-4-(2H-indazol-3-ylmethyl)-5-oxo-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-6-yl]-N-propan-2-ylacetamide
Show/Hide
|
C36H33N7O2
|
1
|
1 |
IC50 = 38.1 nM
|
|
|
CP0517273
|
6-[2-(2-benzylpiperidin-1-yl)-2-oxoethyl]-4-(1H-indol-3-ylmethyl)-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C39H36N6O2
|
1
|
1 |
IC50 = 44.7 nM
|
|
|
CP0537619
|
4-(1H-indol-3-ylmethyl)-6-[2-[2-(2-methoxyethyl)piperidin-1-yl]-2-oxoethyl]-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C35H36N6O3
|
1
|
1 |
IC50 = 49.3 nM
|
|
|
CP0467648
|
(4-(3-fluorophenyl)-5-(4-methoxyphenyl)pyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C31H26FN5O2
|
1
|
1 |
IC50 = 51 nM
|
|
|
CP0441278
|
(5-(4-methoxyphenyl)-4-o-tolylpyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C32H29N5O2
|
1
|
1 |
IC50 = 55 nM
|
|
|
CP0379208
|
(3R)-3-[[2-[[(2R)-2-acetamido-3-(1H-indol-3-yl)propanoyl]amino]-3-[3-[(2-methylphenyl)carbamoylamino]phenyl]propanoyl]amino]-4-[[(2S)-1-amino-3-(4-methylphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
Show/Hide
|
C44H48N8O8
|
1
|
1 |
IC50 = 63.1 nM
|
|
|
CP0460665
|
(4-(1H-indol-6-yl)piperazin-1-yl)(5-(4-methoxyphenyl)-4-p-tolylpyrimidin-2-yl)methanone
Show/Hide
|
C31H29N5O2
|
1
|
1 |
IC50 = 66 nM
|
|
|
CP0527482
|
6-[2-(3-benzylpyrrolidin-1-yl)-2-oxoethyl]-4-(1H-indol-3-ylmethyl)-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C38H34N6O2
|
1
|
1 |
IC50 = 68.6 nM
|
|
|
CP0432117
|
4-(1H-indol-3-ylmethyl)-6-[2-oxo-2-(2-propan-2-ylpiperidin-1-yl)ethyl]-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C35H36N6O2
|
1
|
1 |
IC50 = 80.1 nM
|
|
|
CP0526171
|
(4S)-4-(2H-indazol-3-ylmethyl)-6-[2-[2-[(3-methylphenyl)methyl]piperidin-1-yl]-2-oxoethyl]-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C39H37N7O2
|
1
|
1 |
IC50 = 87.6 nM
|
|
|
CP0432119
|
4-(1H-indol-3-ylmethyl)-6-[2-oxo-2-[2-(pyridin-2-ylmethyl)piperidin-1-yl]ethyl]-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C38H35N7O2
|
1
|
1 |
IC50 = 93.3 nM
|
|
|
CP0425895
|
3-(4-(5-(4-methoxyphenyl)-4-p-tolylpyrimidine-2-carbonyl)piperazin-1-yl)-2-naphthoic acid
Show/Hide
|
C34H30N4O4
|
1
|
1 |
IC50 = 95 nM
|
|
|
CP0374655
|
(3S)-3-[[2-[[(2S)-2-acetamido-3-(1H-indol-3-yl)propanoyl]amino]-3-[3-[(2-methylphenyl)carbamoylamino]phenyl]propanoyl]amino]-4-[[(2R)-1-amino-3-(4-methylphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
Show/Hide
|
C44H48N8O8
|
1
|
1 |
IC50 = 100 nM
|
|
|
CP0437825
|
(3S)-3-[[2-[[(2S)-2-acetamido-3-(1H-indol-3-yl)propanoyl]amino]-3-[4-[(2-chlorophenyl)carbamoylamino]phenyl]propanoyl]amino]-4-[[(2R)-1-amino-3-(4-methylphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
Show/Hide
|
C43H45ClN8O8
|
1
|
1 |
IC50 = 100 nM
|
|
|
CP0036767
|
S-L-365,260
Show/Hide
|
C24H22N4O2
|
1
|
1 |
IC50 = 158.49 nM
|
|
|
CP0425893
|
(5-(2-methoxyphenyl)-4-p-tolylpyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C32H29N5O2
|
1
|
1 |
IC50 = 165 nM
|
|
|
CP0444320
|
4-(1H-indol-3-ylmethyl)-6-[2-oxo-2-(2-phenylpyrrolidin-1-yl)ethyl]-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C37H32N6O2
|
1
|
1 |
IC50 = 168 nM
|
|
|
CP0425894
|
(5-(4-methoxyphenyl)-4-m-tolylpyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C32H29N5O2
|
1
|
1 |
IC50 = 174 nM
|
|
|
CP0549227
|
4-(1H-indol-3-ylmethyl)-6-[2-oxo-2-(2-phenylpiperidin-1-yl)ethyl]-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C38H34N6O2
|
1
|
1 |
IC50 = 248 nM
|
|
|
CP0474584
|
4-(1H-indol-3-ylmethyl)-6-[2-oxo-2-[2-(pyridin-4-ylmethyl)piperidin-1-yl]ethyl]-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C38H35N7O2
|
1
|
1 |
IC50 = 340 nM
|
|
|
CP0408733
|
4-(1H-indol-3-ylmethyl)-6-[2-oxo-2-[2-(pyridin-2-ylmethyl)pyrrolidin-1-yl]ethyl]-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
Show/Hide
|
C37H33N7O2
|
1
|
1 |
IC50 = 373 nM
|
|
|
CP0494369
|
methyl 3-[4-[5-(4-methoxyphenyl)-4-(4-methylphenyl)pyrimidine-2-carbonyl]piperazin-1-yl]naphthalene-2-carboxylate
Show/Hide
|
C35H32N4O4
|
1
|
1 |
IC50 = 587 nM
|
|
|
CP0372232
|
(5-(3,4-dimethoxyphenyl)-4-p-tolylpyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C33H31N5O3
|
1
|
1 |
IC50 = 857 nM
|
|
|
CP0441280
|
(5-(3,4-dihydroxyphenyl)-4-p-tolylpyrimidin-2-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone
Show/Hide
|
C31H27N5O3
|
1
|
1 |
IC50 = 1632 nM
|
|
|
CP0534072
|
(5-(3-methoxyphenyl)-6-p-tolylpyrazin-2-yl)(4-(naphthalen-2-yl)piperazin-1-yl)methanone
Show/Hide
|
C33H30N4O2
|
1
|
1 |
IC50 = 2925 nM
|
|
|
CP0372227
|
(5-(3-methoxyphenyl)-6-p-tolylpyridin-3-yl)(4-(naphthalen-2-yl)piperazin-1-yl)methanone
Show/Hide
|
C34H31N3O2
|
1
|
1 |
IC50 > 10000 nM
|
|
|
CP0520968
|
(6-(3-methoxyphenyl)-5-p-tolylpyrazin-2-yl)(4-(naphthalen-2-yl)piperazin-1-yl)methanone
Show/Hide
|
C33H30N4O2
|
1
|
1 |
IC50 > 10000 nM
|
|
|
CP0516272
|
(3S)-3-[[(2S)-2-[[(2S)-2-acetamido-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-[[(2R)-1-amino-3-(4-methylphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
Show/Hide
|
C36H40N6O7
|
1
|
1 |
IC50 < 100000 nM
|
|
|
CP0881710
|
2-(5-cyclohexyl-1-(3,3-dimethyl-2-oxo-butyl)-2-oxo-1,2-dihydro-3H-1,3,4-benzotriazepin-3-yl)-N-(3-hydroxy-phenyl)-acetamide
Show/Hide
|
C28H34N4O4
|
1
|
1 |
Ki = 1513.56 nM
|
|
|
CP0918904
|
2-(5-cyclohexyl-1-(3,3-dimethyl-2-oxo-butyl)-2-oxo-1,2-dihydro-3H-1,3,4-benzotriazepin-3-yl)-N-(3-(methyl-(2-methylaminoethyl)-amino)-phenyl)-acetamide
Show/Hide
|
C32H44N6O3
|
1
|
1 |
Ki = 8709.64 nM
|
|
|